Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.315 USD | +0.49% | +2.75% | -16.76% |
Financials (USD)
Sales 2024 * | 58.64M | Sales 2025 * | 71.15M | Capitalization | 253M |
---|---|---|---|---|---|
Net income 2024 * | 14M | Net income 2025 * | 26M | EV / Sales 2024 * | 4.32 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.56 x |
P/E ratio 2024 * |
16.8
x | P/E ratio 2025 * |
9.95
x | Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.7% |
Latest transcript on Fennec Pharmaceuticals Inc.
1 day | -0.86% | ||
1 week | +1.98% | ||
Current month | +0.98% | ||
1 month | -14.40% | ||
3 months | -8.49% | ||
6 months | +21.65% | ||
Current year | -17.38% |
Managers | Title | Age | Since |
---|---|---|---|
Rostislav Raykov
CEO | Chief Executive Officer | 48 | 09-07-06 |
Robert Andrade
DFI | Director of Finance/CFO | 49 | 09-07-06 |
Adrian Haigh
COO | Chief Operating Officer | 64 | 14-04-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chris Rallis
BRD | Director/Board Member | 70 | 11-08-24 |
Khalid Islam
CHM | Chairman | 67 | 14-04-24 |
Robert Andrade
DFI | Director of Finance/CFO | 49 | 09-07-06 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 0 M€ | +3.45% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 9.34 | +0.76% | 10 943 |
24-05-08 | 9.27 | -0.86% | 38,946 |
24-05-07 | 9.35 | +2.86% | 54,392 |
24-05-06 | 9.09 | -1.52% | 88,712 |
24-05-03 | 9.23 | +1.54% | 71,279 |
Delayed Quote Nasdaq, May 08, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.38% | 253M | |
+2.93% | 108B | |
-0.44% | 23.46B | |
-14.60% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-8.83% | 17.19B | |
+5.51% | 13.99B | |
+37.49% | 12.53B | |
+329.39% | 8.81B |
- Stock Market
- Equities
- FENC Stock